AirBridgeCargo Airlines ships vaccine candidate for clinical trials
Some 6,000 doses of the Ad5-nCoV vaccine candidate by CanSinoBIO were transported from Beijing, reportedly for clinical trials.
December 1, 2020
By PLA Editor
Air & Cargo Services air cargo Air Cargo Asia air cargo freight Air Forwarding air freight Air Freight Asia Air Freight Logistics air freighter air freighting Air Logistics Asia Air Shipping Asia AirBridgeCargo airlines cargo airways cargo asia cargo news cargo aviation Covid-19 vaccine Marken UPS Healthcare
AirBridgeCargo Airlines successfully delivered CanSinoBIO‘s Covid-19 vaccine candidate in partnership with UPS/Marken. This marked its first completed vaccine transportation from Beijing (China) to an unmentioned destination as part of clinical trials in various countries across the globe.
The carrier’s Boeing 747 freighter carried a total of 6,000 doses of the Ad5-nCoV vaccine, weighing almost 400 kilograms, packed into a CRЗDO™ XTREME a passive container, stacked and loaded into a standard AKE container and delivered under 2°C to 8°C.
“After months of preparations, we are actually stepping into the COVID-19 vaccine transportation phase to deliver these sophisticated pharmaceutical products the whole world relies on as a source which will help all of us to get back to normal,” said Casper Pan, vaccine task force lead and APAC head of healthcare for Volga-Dnepr Group.
Yulia Celetaria, healthcare director of Volga-Dnepr Group, thanked UPS for ensuring vaccine efficacy was fully maintained throughout the journey. “We hope for further cooperation through our joint shipments, workshops and follow-up online meetings,” she added.